Home LiteratureArticle Details
PMID: 8044933 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.

Circulation ·Vol. 90 ·No. 2 ·1994-08-00 ·Pages 649-52

Brogi E, Wu T, Namiki A, Isner JM

Abstract

Hypoxia and indirect angiogenic factors may stimulate angiogenesis via induction of endothelial cell mitogen(s). To evaluate this hypothesis, we investigated whether low oxygen tension or cytokines known to promote neovascularization in vivo could modulate the expression of either vascular endothelial growth factor (VEGF) or basic fibroblast growth factor (bFGF) in human vascular smooth muscle cells (SMCs). SMCs were treated with platelet-derived growth factor BB (PDGF-BB) or transforming growth factor-beta 1 (TGF-beta 1) or exposed to low oxygen tension in serum-free medium. Northern analysis detected low basal levels of VEGF and bFGF mRNA in extracts of unstimulated SMCs. However, both VEGF and bFGF transcripts increased after administration of PDGF-BB (10 or 20 ng/mL) or TGF-beta 1 (0.1 to 10 ng/mL). Hypoxia was a potent stimulus for VEGF gene expression but had no apparent effect on bFGF steady-state mRNA levels. These results indicate that certain indirect angiogenic cytokines, such as PDGF-BB or TGF-beta 1, may act via induction of bFGF and VEGF gene expression in cells resident near endothelial cells in vivo. Hypoxia constitutes a potent stimulus for VEGF gene expresion but does not regulate bFGF under the same experimental conditions.

MeSH Terms
Becaplermin Blotting, Northern Cell Hypoxia Endothelial Growth Factors/biosynthesis,genetics Fibroblast Growth Factor 2/biosynthesis,genetics Gene Expression/physiology Humans In Vitro Techniques Lymphokines/biosynthesis,genetics Muscle, Smooth, Vascular/metabolism Platelet-Derived Growth Factor/pharmacology Proto-Oncogene Proteins c-sis RNA, Messenger/genetics Recombinant Proteins/pharmacology Transforming Growth Factor beta/pharmacology Up-Regulation Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Lymphokines Platelet-Derived Growth Factor Proto-Oncogene Proteins c-sis RNA, Messenger Recombinant Proteins Transforming Growth Factor beta Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Fibroblast Growth Factor 2 Becaplermin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Brogi E
Department of Medicine (Cardiology), St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass.
Wu T
Namiki A
Isner J M
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
0009-7322
Published
1994-08-00
Pages
649-52
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NHLBI NIH HHS · HL-02824 · United States
NHLBI NIH HHS · HL-40518 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com